The ecology of prescription opioid abuse in the USA: Geographic variation in patients' use of multiple prescribers ("doctor shopping")

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 12, 2014, Pages 1258-1267

  Mcdonald, Douglas C ^a   Carlson, Kenneth E ^a  

^a ABT ASSOCIATES   (United States)

Author keywords

Abuse; Diversion; Geographic variation; Multiple prescribers; Opioids; Pharmacoepidemiology

Indexed keywords

PRESCRIPTION DRUG;

AGE; CLINICAL PRACTICE; CLUSTER ANALYSIS; DRUG MISUSE; HUMAN; OPIOID-RELATED DISORDERS; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGE FACTORS; ALASKA; HUMANS; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUG MISUSE; PRESCRIPTION DRUGS; RHODE ISLAND; SEX FACTORS; SMALL-AREA ANALYSIS; UNITED STATES;

EID: 84913530496     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3690     Document Type: Article

References (63)

1. Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses-a U.S. epidemic. MMWR Morb Mortal Wkly Rep 2012; 61: 10-13.
2. Alexander GC, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. JAMA 2012; 308: 1865-1866. doi:10.1001/jama.2012.14282.
3. Chen L-H, Hedegaard H, Warner M. QuickStats: number of deaths from poisoning, drug poisoning, and drug poisoning involving opioid analgesics-United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2013; 62: 234.
4. Warner M, Chen LH, Makuc DM, Anderson RN, Miniño AM. Drug poisoning deaths in the United States, 1980-2008. NCHS data brief, no 81. National Center for Health Statistics, Hyattsville, MD, 2011. http://www.cdc.gov/nchs/data/databriefs/db81.htm (accessed 10 November 2013)
5. Substance Abuse and Mental Health Services Administration. Emergency department trends from the Drug Abuse Warning Network, final estimates 1995-2002. DAWN Series: D-24. Office of Applied Studies, Rockville, MD, 2003. http://www.samhsa.gov/data/driverrprt/dawn2k2/edfinal2k2.pdf (12 November 2013).
6. Substance Abuse and Mental Health Services Administration. The DAWN report: highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. Center for Behavioral Health Statistics and Quality, Rockville, MD, 2013. http://www.samhsa.gov/data/2k13/DAWN127/sr127-DAWN-highlights.pdf (20 November 2013).
7. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS) highlights-2007 National Admissions to Substance Abuse Treatment Services. Office of Applied Studies, Rockville, MD, 2009. http://www.samhsa.gov/data/TEDS2k7highlights/TEDSHigh2k7.pdf (13 November 2013).
8. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 2000-2010. National Admissions to Substance Abuse Treatment Services. DASIS. Center for Behavioral Health Statistics and Quality, Rockville, MD, 2012. http://www.samhsa.gov/data/2k12/TEDS2010N/TEDS2010NWeb.pdf (11 November 2013).
9. Dijkstra A, Hak E, Janssen F. A systematic review of the application of spatial analysis in pharmacoepidemiologic research. Ann Epidemiol 2013; 23: 504-514. DOI: 10.1016/j.annepidem.2013.05.015, S1047-2797(13)00153-1 [pii]
10. Substance Abuse and Mental Health Services Administration. The NSDUH report: state estimates of nonmedical use of prescription pain relievers. Rockville, MD, 2013. http://www.samhsa.gov/data/2k12/NSDUH115/sr115-nonmedical-use-pain-relievers.htm (May 5, 2013).
11. Rossen LM, Khan D, Warner M. Hot spots in mortality from drug poisoning in the United States, 2007-2009. Health Place 2014; 26: 14-20. DOI: 10.1016/j.healthplace.2013.11.005 S1353-8292(13)00155-X [pii]
12. Smith MY, Irish W, Wang J, Haddox JD, Dart RC. Detecting signals of opioid analgesic abuse: application of a spatial mixed effect Poisson regression model using data from a network of poison control centers. Pharmacoepidemiol Drug Saf 2008; 17: 1050-1059.
13. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2011: national estimates of drug-related emergency department visits. Rockville, MD, 2013.
14. Office of National Drug Control Policy. ADAM II: 2011 annual report, Arrestee Drug Abuse Monitoring Program II. Office of National Drug Control Policy, Executive Office of the President, Washington, D.C., 2012.
15. Brownstein JS, Green TC, Cassidy TA, Butler SF. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol Drug Saf 19: 627-637.
16. Cerda M, Ransome Y, Keyes KM, et al. Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug Alcohol Depend 2013; 132: 53-62. DOI: 10.1016/j.drugalcdep.2012.12.027 S0376-8716(13)00003-3 [pii]
17. Gomes T, Juurlink D, Moineddin R, et al. Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthc Q 2011; 14: 22-24.
18. Keyes KM, Cerda M, Brady JE, Havens JR, Galea S. Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health 2014; 104: e52-e59. doi:10.2105/AJPH.2013.301709.
19. Havens JR, Walker R, Leukefeld CG. Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend 2007; 87: 98-102. S0376-8716(06)00285-7 [pii] DOI: 10.1016/j.drugalcdep.2006.07.008
20. Leukefeld CG, Narevic E, Hiller ML, et al. Alcohol and drug use among rural and urban incarcerated substance abusers. Int J Offender Ther Comp Criminol 2002; 46: 715-728.
21. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300: 2613-2620. doi:10.1001/jama.2008.802.
22. Green TC, Grau LE, Carver HW, Kinzly M, Heimer R. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. Drug Alcohol Depend 2011; 115: 221-228. DOI: 10.1016/j.drugalcdep.2010.11.007 S0376-8716(10)00382-0 [pii]
23. Wilsey BL, Fishman SM, Gilson AM, et al. An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program. Pharmacoepidemiol Drug Saf 2011; 20: 1262-1268. doi:10.1002/pds.2129.
24. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: summary of national findings. Rockville, MD, 2012. http://www.samhsa.gov/data/nsduh/2k11results/nsduhresults2011.htm (20 November 2016).
25. Pierce TG. Gen-X junkie: ethnographic research with young White heroin users in Washington, DC. Subst Use Misuse 1999; 34: 2095-2114.
26. Rigg KK, Kurtz SP, Surratt HL. Patterns of prescription medication diversion among drug dealers. Drugs (Abingdon Engl) 2012; 19: 144-155. doi:10.3109/09687637.2011.631197.
27. Mattison AM, Ross MW, Wolfson T, Franklin D. Circuit party attendance, club drug use, and unsafe sex in gay men. J Subst Abuse 2001; 13: 119-126. S0899-3289(01)00060-8 [pii]
28. Miller M. History and epidemiology of amphetamine abuse in the United States. In Amphetamine Misuse: International Perspectives on Current Trends, Klee H (ed.). Harwood Academic Publishers: Amsterdam, 1997; 113-133.
29. Curtis R. Crack, cocaine and heroin: drug eras in Williamsburg, Brooklyn, 1960-2000. Addiction Res Theor 2003; 11: 47-63.
30. Bourgeois P. In search of Horatio Alger: culture and ideology in the crack economy. In Crack in America, Reinarman C, Levine HG (eds.). University of California Press: Berkeley, California, 1997: 57-76.
31. McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain 2012; 13: 988-996. doi:10.1016/j.jpain.2012.07.007.
32. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care 2009; 15: 897-906.
33. Paulozzi LJ, Kilbourne EM, Shah NG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 2012; 13: 87-95. doi:10.1111/j.1526-4637.2011.01260.x.
34. Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled substances. Med Care 2012; 50: 494-500. doi:10.1097/MLR.0b013e31824ebd81.
35. Baumblatt JAG, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med 2014. doi:10.1001/jamainternmed.2013.2711.
36. Von Korff M, Dunn KM. Chronic pain reconsidered. Pain 2008; 138: 267-276. DOI: 10.1016/j.pain.2007.12.010 S0304-3959(07)00750-6 [pii]
37. Eastern Metropolitan Region Palliative Care Consortium Clinical Working Party. Opioid conversion ratios-guide to practice. In: Consortium EMRPC, ed. Victoria, Australia, 2008.
38. Paulozzi LJ, Jones CM, Mack KA, Rudd RA. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2011; 60: 1487-1492.
39. U.S. Dept of Health and Human Services. Area Resource File (ARF) Access System 2008. Health Resources and Services Administration, Rockville, MD, 2008. http://arf.hrsa.gov/index.htm
40. Katz N, Panas L, Kim M, et al. Usefulness of prescription monitoring programs for surveillance-analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf 2010; 19: 115-123. doi:10.1002/pds.1878.
41. Wilsey BL, Fishman SM, Gilson AM, et al. Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. Drug Alcohol Depend 2010; 112: 99-106. doi:10.1016/j.drugalcdep.2010.05.007.
42. Cepeda M, Fife D, Mastrogiovanni G, Henderson CS. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US. Drug Saf 2012; 35: 325-334.
43. Cepeda M, Fife D, Mastrogiovanni G, Henderson CS. Opioid shopping behavior: how often, how soon, which drugs, and what payment method. J Clin Pharmacol 2012; 53: 112-117.
44. Deb P. FMM: Stata module to estimate finite mixture models. EconPapers 2012; http://econpapers.repec.org/software/bocbocode/s456895.htm. Accessed 10 February, 2012.
45. McLachlan G, Peel D. Finite Mixture Models. John Wiley & Sons, Inc.: New York, 2000.
46. McDonald DC, Carlson KE. Estimating the prevalence of opioid diversion by "doctor shoppers" in the United States. PLoS One 2013; 8: e69241.
47. Katz N, Panas L, Kim M, et al. Usefulness of prescription monitoring programs for surveillance-analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf 2010; 19: 115-123. doi:10.1002/pds.1878.
48. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008; 9: 444-459.
49. Schneider MF, Bailey JE, Cicero TJ, et al. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf 2009; 18: 778-790. doi:10.1002/pds.1780.
50. Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf 2007; 16: 827-840. doi:10.1002/pds.1452.
51. Cepeda MS, Fife D, Yuan Y, Mastrogiovanni G. Distance traveled and frequency of interstate opioid dispensing in opioid shoppers and nonshoppers. J Pain 2013; 14: 1158-1161. DOI: 10.1016/j.jpain.2013.04.014 S1526-5900(13)00992-9 [pii]
52. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings. NSDUH Series H-25. Rockville, MD, 2004.
53. Alliance of States with Prescription Monitoring Programs. Status of Prescription Drug Monitoring Programs (PDMPs), 2012; http://www.pmpalliance.org/pdf/pmp_status_map_2012.pdf. Accessed 14 August 2013.
54. The MITRE Corporation. Enhancing access to Prescription Drug Monitoring Programs using health information technology: work group recommendations. McLean, VA: The MITRE Corporation; August 17, 2012 2012.
55. Kirschner N, Ginsburg J, Sulmasy LS. Prescription drug abuse: executive summary of a policy position paper from the American College of Physicians. Ann Intern Med 2014; 160: 198. DOI: 10.7326/M13-2209 1788221 [pii]
56. Prescription Drug Monitoring Program Center of Excellence. Mandating PDMP Participation by Medical Providers: Current Status and Experience in Selected States. Brandeis University: Waltham, MA, 2014.
57. Tudor CG. Memorandum: Medicare Part D Overutilization Monitoring System. Center for Medicare, Centers for Medicare & Medicaid Services, Department of Health & Human Services, Baltimore; July 5, 2013. http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/HPMS-memo-Medicare-Part-D-Overutilization-Monitoring-System-07-05-13-.pdf (1 December 2013).
58. Blue Cross Blue Shield of Massachusetts. New quality and safety measures in opioid management, Effective July 1, 2012. 2012; https://www.bluecrossma.com/bluelinks-for-employers/whats-new/special-announcements/opioid-management.html. Accessed May 3, 2014, 2014.
59. Trafton J, Martins S, Michel M, et al. Evaluation of the acceptability and usability of a decision support system to encourage safe and effective use of opioid therapy for chronic, noncancer pain by primary care providers. Pain Med 2010; 11: 575-585. 10.1111/j.1526-4637.2010.00818.x PME818 [pii]
60. Wohl J. CVS cuts access to opioid pain-killers for suspect doctors. Reuters 2013.
61. Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility. Pain Physician 2008; 11: S155-S180.
62. Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014; 160: 38-47. DOI: 10.7326/0003-4819-160-1-201401070-00732 1767856 [pii]
63. Drug Enforcement Administration. Automation of Reports and Consolidated Orders System (ARCOS) Retail Summary Reports. Office of Diversion Control, 2008-2011.